HYGIEIA. REFORMING INSULIN THERAPY AS WE KNOW IT.

We are Hygieia. And we are singularly focused on revolutionizing how people manage their insulin. Using science, research and technology, we developed a breakthrough and highly effective insulin management program that not only changes how patients and physicians manage insulin today, but also establishes the standard of autonomous insulin dose adjustment.
With over seven million Americans with type 2 diabetes using insulin and only 33% achieving successful results, the need for a monumental shift in insulin management has never been greater. Hygieia’s founders, Dr. Eran Bashan and Dr. Israel Hodish answer the call with d-Nav® Technology2 — an FDA-cleared breakthrough insulin management tool designed to significantly improve and simplify insulin treatment so that more people who are on insulin therapy succeed.
From inception, it has been our mission to redefine the way the world manages insulin, and we are committed to leading the charge.
MANAGEMENT TEAM

Eran Bashan, PhD
CEO and Chairman

Mary Ann Tournoux
Chief Commercial Officer

Mark Willis
Chief Technology Officer

Israel Hodish, MD, PhD
Medical Director

Jean Herbison
Vice President of Operations

Sheraz Bakhsh
Controller

Donna McCollum
Vice President of Research and Development
BOARD OF DIRECTORS

John Brooks

Mark Hirschhorn

Charles Bisgaier

Nir Tarlovsky
ADVISORY BOARD

Richard M. Bergenstal, MD
Executive Director, IDC

George Grunberger, MD
FACP, MACE

Mark Fendrick, MD

Michael J. Miller, MD

Karen Drexler
NEWS
Discover important news about d-Nav and type 2 diabetes.
CONTACT
Let us know if we can help.